Company Overview and News
(Oct 19): Exxon Mobil Corp. is targeting western and southern Africa for the world’s next big oil bonanza as the explorer scours the globe to repeat its success in Guyana.
FP RDS.B RDS.A XOM RYDBF TLW RDSB RDSA RYDAF
(Bloomberg) -- Exxon Mobil Corp. is targeting western and southern Africa for the world’s next big oil bonanza as the explorer scours the globe to repeat its success in Guyana.
FP RDS.B RDS.A XOM RYDBF TLW RDSB RDSA RYDAF
Dublin and London - October 4, 2018 - Providence Resources P.l.c. (PVR LN, PRP ID), the Irish based Oil & Gas Exploration Company, today announces the appointment of Dr Angus McCoss as Senior Independent Director with immediate effect. Dr McCoss joined the Providence Board as a Non-Executive Director in June 2017.
Oil Price With WTI up by $1.79 last week and a modest gain of 78c for Brent, the Opec+ meeting in Algeria was always going to be the decider for this morning's opening. As it is, with WTI up $1.48 at $72.26 and Brent up $1.96 to $80.76 as I write, when he wakes up Mr President is going to get Tweeting.
TLW PPCGF PPC
Eco (Atlantic) Oil & Gas Ltd. (AIM: ECO, TSX-V: EOG), the oil and gas exploration company with licences in highly prospective regions in Namibia and Guyana, is delighted to announce that Total E&P Activités Pétrolières, a wholly owned subsidiary of Total Petroleum SA (“Total”), has exercised its option to acquire a 25% Working Interest in the Orinduik Block, offshore Guyana, from Eco Atlantic (Guyana) Inc.
Okay. Good morning, everybody. Welcome to Cairn's Half Yearly Results Presentation. I'm Simon Thomson, Chief Executive. With me are James Smith, CFO; Paul Mayland, COO, and Eric Hathon, Exploration Director.
CNE CRNZF TLW MS CRNCY
LONDON, Sept 11 (Reuters) - A prospect operated by Tullow Oil off Guyana contains an estimated 3 billion barrels of oil and gas, its partner Eco Atlantic said on Tuesday, as the two firms prepare to drill in the Latin American oil basin.
LONDON, United Kingdom, September 6, 2018/ -- Africa Oil Week (AOW) (www.Africa-OilWeek.com) has announced their partnership with SuperReturn. This new partnership offers delegates attending SuperReturn Africa, the continent's biggest investor conference, access to Africa Oil Week on Thursday 8 November 2018. For operators across the continent, raising capital remains one of the biggest challenges; whether it is funding exploration and production, or financing key infrastructure projects that will secure asset monetization for the long term.
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
Silicon Investor Message Boards
This table lists all message boards related to LSE:TLW / TULLOW OIL PLC on message board site Silicon Investor.
|STLW: Stratos Lightwave, Inc.||STLW: Stratos Lightwave, Inc.||STLW: Stratos Lightwave, Inc.||STLW||STLW||STLW|
|Trim a Lawn - (TLWN)||Trim a Lawn - (TLWN)||Trim a Lawn - (TLWN)|